Summary
This is a patent-infringement decision concerning Congoleum Industries' patents for chemically embossed foam vinyl products and processes. The court makes detailed findings regarding the patented technology, patent disclosure, anticipation, obviousness, and prior art. The excerpt ends during the findings of fact and does not show the complete disposition or final page of the opinion.
Topics
Practice areas
Questions Presented
- Whether the patents were anticipated by the cited prior art under 35 U.S.C. § 102.
- Whether the claimed inventions were obvious under 35 U.S.C. § 103.
- Whether the patent specifications satisfied the written-description, enablement, and definiteness requirements of 35 U.S.C. § 112.
- Whether continuation-in-part applications impermissibly broadened the claims after the statutory public-use or on-sale period under 35 U.S.C. §§ 102(b) and 120.
- Whether the named inventors were the true joint inventors and whether the patents were invalid because of alleged fraud on the Patent Office.
- Whether Armstrong's commercial process and products infringed specified claims of the two patents.
- Whether Armstrong's infringement was willful and wanton, supporting enhanced damages or attorney's fees.
Holdings
- The patents were not anticipated because none of the cited prior-art references identically disclosed a process using an inhibitor printed on a gelled plastisol to penetrate the gel and substantially alter the blowing-agent decomposition temperature to produce chemical embossing.
- The claimed process and products were not obvious under 35 U.S.C. § 103.
- The specifications satisfied 35 U.S.C. § 112 because they defined an inhibitor and provided a simple test enabling a skilled person to determine whether an unlisted compound would function as an inhibitor; the term decomposition temperature was sufficiently clear in the context of foam vinyl technology.
- The continuation-in-part applications and the resulting patents were entitled to the filing date of the parent application under 35 U.S.C. § 120, so the public-use and on-sale bar of § 102(b) did not invalidate the patents.
- Nairn, Harkins, Ehrenfeld, and Tarlow were the true joint inventors, and Armstrong failed to prove improper inventorship or fraud on the Patent Office by clear, unequivocal, and convincing evidence.
- Armstrong's commercial process infringed specified claims of Patent No. 3,293,094, and Armstrong's commercial products infringed specified claims of Patent No. 3,293,108, because benzoyl peroxide or its decomposition products substantially altered the blowing-agent decomposition temperature and caused the embossed effect.
- Armstrong's infringement was not willful and wanton, so Congoleum did not establish entitlement on that basis to treble damages or attorney's fees.
Key quotations
“The test for determining if a claim of a patent has been anticipated by a prior reference is whether that reference contains, within its four corners, adequate directions for the practice of the patent claim sought to be invalidated.” (339 F. Supp. at 1052)
“For purposes of determining infringement, a substantial alteration of the decomposition temperature means sufficient alteration to cause enough embossing so that the process may be utilized to enhance the commercial saleability of a product.” (339 F. Supp. at 1063)
Factual background
Congoleum owned patents covering a chemical embossing process and textured foam products for vinyl floor coverings. The patented process used an inhibitor printed in selected areas of a gelled foamable plastisol to alter the decomposition temperature of a blowing agent and create embossed areas registered with the printed design. Armstrong manufactured competing chemically embossed vinyl flooring using benzoyl peroxide in selected inks and argued that embossing resulted solely from polymerization, cross-linking, and physical restriction of the foam. The court found that benzoyl peroxide or its decomposition products substantially altered the blowing-agent decomposition temperature and that this mechanism caused the infringing embossed effect.
Procedural history
Congoleum, the assignee and owner of the patents, sued Armstrong for infringement of United States Patents Nos. 3,293,094 and 3,293,108. After a bench trial, the district court rejected Armstrong's invalidity defenses, found both patents valid, found infringement of specified claims, and rejected Congoleum's claims for willful and wanton infringement. The court deferred determination of Congoleum's entitlement to an accounting and injunction pending further proceedings.
Remand instructions
No remand was ordered. The determination of Congoleum's right to an accounting and an injunction was deferred pending appropriate future proceedings.